These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31044750)

  • 1. Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients.
    Ahmed FA; Bajaifar MS; Ahmed MA; Alalwan A; Sanai FA; Albeladi K; Aljumah AA; Sanai FM
    Saudi J Gastroenterol; 2019; 25(5):286-292. PubMed ID: 31044750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
    Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
    Balkan A; Namiduru M; Balkan Y; Mete AO; Karaoglan I; Bosnak VK
    Saudi J Gastroenterol; 2016; 22(3):208-14. PubMed ID: 27184639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
    Ungtrakul T; Sriprayoon T; Kusuman P; Chunnuan P; Soonklang K; Sornsamdang G; Auewarakul CU; Tanwandee T
    Medicine (Baltimore); 2017 Mar; 96(13):e6554. PubMed ID: 28353619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large spontaneous HBV DNA fluctuations and potential usefulness of a single-point measurement of combined HBV DNA and quantitative HBsAg for the exclusion of HBeAg-negative chronic hepatitis B: A prospective Tunisian cohort study.
    Chtourou A; Gargouri S; Elleuch E; Feki L; Smaoui F; Taktak A; Mnif K; Kassis M; Hammami A; Ben Jemaa M; Karray H
    Arab J Gastroenterol; 2023 Nov; 24(4):223-229. PubMed ID: 37989673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels.
    Gan Q; Huang Y; Zhu C; Zhao S; Fu H; Cai M; Wang J; Zhang C; Guo S; Cao Z; Xie Q
    Can J Gastroenterol Hepatol; 2022; 2022():8695196. PubMed ID: 35875362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
    Chien TL; Wang JH; Kee KM; Chen CH; Hung CH; Lu SN
    PLoS One; 2016; 11(12):e0166543. PubMed ID: 27935953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir.
    Gish RG; Chang TT; Lai CL; de Man RA; Gadano A; Llamoso C; Tang H
    Antivir Ther; 2013; 18(5):691-8. PubMed ID: 23510982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase.
    Wang J; Zhu L; Zhang Z; Zhang S; Pan Y; Li Y; Cao F; Jiang C; Fan T; Xiong Y; Liu J; Chen Y; Yin S; Tong X; Zhu C; Liu X; Li J; Wu C; Huang R
    Virol J; 2024 Jun; 21(1):127. PubMed ID: 38835029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between HBV viral load and severity of liver inflammation in patients with chronic hepatitis B virus infection].
    Xing TJ; Zhao KY; Li WT; Wang LJ; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):954-960. PubMed ID: 37872091
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.
    Ramachandran J; Ismail AM; Chawla G; Fletcher GJ; Goel A; Eapen CE; Abraham P
    Indian J Gastroenterol; 2014 Mar; 33(2):131-5. PubMed ID: 24052375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
    Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
    Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative hepatitis B surface antigen titres in Chinese chronic hepatitis B patients over 4 years of entecavir treatment.
    Chen EQ; Wang TT; Bai L; Tao CM; Liang T; Liu C; Liao J; Tang H
    Antivir Ther; 2013; 18(8):955-65. PubMed ID: 23639885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
    Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
    J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels.
    Sanai FM; Alhouthali AH; Alghamdi HS; Badriq F; Sanai EA; Mujalled MK; Khayyat W; Attar MS; Bagadeem BS; Meer AM; Alshumrani W; Albeladi K; AlTraif I; Alqahtani S
    Saudi J Gastroenterol; 2022; 28(5):341-347. PubMed ID: 35488588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.